In a study performed by Tansley et al., composed primarily of white patients (76%), anti-MDA5 antibodies were identified in only 7.4% of JDM patients and were associated with distinct clinical phenotypes, including skin & oral ulceration, arthritis, and milder muscle disease (compared with patients without MDA-5 antibodies). The gene discussed is IFIH1; the disease is juvenile dermatomyositis.